Lung-on-a-chip Market, Global Outlook and Forecast 2024-2030

Lung-on-a-chip Market, Global Outlook and Forecast 2024-2030

Report Code: KNJ1765276 | No. of Pages: 65 | Category: Medical Devices
Publisher: Market Monitor Global | Date of Publish: Mar-2024
The global Lung-on-a-chip market is projected to reach US$ million by 2030.
Lung on a chip. The device is made using human lung and blood vessel cells and it can predict absorption of airborne nanoparticles and mimic the inflammatory response triggered by microbial pathogens. It can be used to test the effects of environmental toxins, absorption of aerosolized therapeutics, and the safety and efficacy of new drugs.
This report contains market size and forecasts of Lung-on-a-chip in Global, including the following market information:
Global Lung-on-a-chip Market Size 2025-2030, ($ millions)
Following a strong growth of 26.2 percent in the year 2021, WSTS revised it down to a single digit growth for the worldwide semiconductor market in 2022 with a total size of US$580 billion, up 4.4 percent. WSTS lowered growth estimation as inflation rises and end markets seeing weaker demand, especially those exposed to consumer spending. While some major categories are still double-digit year-over-year growth in 2022, led by Analog with 20.8 percent, Sensors with 16.3 percent, and Logic with 14.5 percent growth. Memory declined with 12.6 percent year over year. In 2022, all geographical regions showed double-digit growth except Asia Pacific. The largest region, Asia Pacific, declined 2.0 percent. Sales in the Americas were US$142.1 billion, up 17.0% year-on-year, sales in Europe were US$53.8 billion, up 12.6% year-on-year, and sales in Japan were US$48.1 billion, up 10.0% year-on-year. However, sales in the largest Asia-Pacific region were US$336.2 billion, down 2.0% year-on-year.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Lung-on-a-chip companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Lung-on-a-chip Market, by Type, 2025-2030 ($ millions)
Global Lung-on-a-chip Market Segment Percentages, by Type
    Pulmonary Inflammation
    Pulmonary Infection
Global Lung-on-a-chip Market, by Application, 2025-2030 ($ millions)
Global Lung-on-a-chip Market Segment Percentages, by Application
    Pharmaceutical & Biotechnology Companies
    Academic & Research Institutes
    Other End Users
Global Lung-on-a-chip Market, By Region and Country, 2025-2030 ($ Millions)
Global Lung-on-a-chip Market Segment Percentages, by region and country
        United States
        Europe
        Asia
        China
        Rest of World
Competitor Analysis
The report also provides analysis of leading market participants including:
Further, the report presents profiles of competitors in the market, key players include:
    Emulate
    Tissuse
    Hesperos
    CN Bio Innovations
    Draper Laboratory
    Mimetas
    Nortis
    Kirkstall
    Cherry Biotech SAS
    Else Else Kooi Laboratory
    Micronit Microtechnologies B.V.
1 Introduction to Research & Analysis Reports
    1.1 Lung-on-a-chip Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Lung-on-a-chip Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Lung-on-a-chip Overall Market Size
    2.1 Global Lung-on-a-chip Market Size: 2024 VS 2030
    2.2 Global Lung-on-a-chip Market Size, Prospects & Forecasts: 2024-2030
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Key Lung-on-a-chip Players in Global Market
    3.2 Global Companies Lung-on-a-chip Product & Technology
4 Lung-on-a-chip Companies Profiles
    4.1 Emulate
        4.1.1 Emulate Company Summary
        4.1.2 Emulate Business Overview
        4.1.3 Emulate Lung-on-a-chip Product Offerings & Technology
        4.1.4 Emulate Lung-on-a-chip R&D, and Plans
    4.2 Tissuse
        4.2.1 Tissuse Company Summary
        4.2.2 Tissuse Business Overview
        4.2.3 Tissuse Lung-on-a-chip Product Offerings & Technology
        4.2.4 Tissuse Lung-on-a-chip R&D, and Plans
    4.3 Hesperos
        4.3.1 Hesperos Company Summary
        4.3.2 Hesperos Business Overview
        4.3.3 Hesperos Lung-on-a-chip Product Offerings & Technology
        4.3.4 Hesperos Lung-on-a-chip R&D, and Plans
    4.4 CN Bio Innovations
        4.4.1 CN Bio Innovations Company Summary
        4.4.2 CN Bio Innovations Business Overview
        4.4.3 CN Bio Innovations Lung-on-a-chip Product Offerings & Technology
        4.4.4 CN Bio Innovations Lung-on-a-chip R&D, and Plans
    4.5 Draper Laboratory
        4.5.1 Draper Laboratory Company Summary
        4.5.2 Draper Laboratory Business Overview
        4.5.3 Draper Laboratory Lung-on-a-chip Product Offerings & Technology
        4.5.4 Draper Laboratory Lung-on-a-chip R&D, and Plans
    4.6 Mimetas
        4.6.1 Mimetas Company Summary
        4.6.2 Mimetas Business Overview
        4.6.3 Mimetas Lung-on-a-chip Product Offerings & Technology
        4.6.4 Mimetas Lung-on-a-chip R&D, and Plans
    4.7 Nortis
        4.7.1 Nortis Company Summary
        4.7.2 Nortis Business Overview
        4.7.3 Nortis Lung-on-a-chip Product Offerings & Technology
        4.7.4 Nortis Lung-on-a-chip R&D, and Plans
    4.8 Kirkstall
        4.8.1 Kirkstall Company Summary
        4.8.2 Kirkstall Business Overview
        4.8.3 Kirkstall Lung-on-a-chip Product Offerings & Technology
        4.8.4 Kirkstall Lung-on-a-chip R&D, and Plans
    4.9 Cherry Biotech SAS
        4.9.1 Cherry Biotech SAS Company Summary
        4.9.2 Cherry Biotech SAS Business Overview
        4.9.3 Cherry Biotech SAS Lung-on-a-chip Product Offerings & Technology
        4.9.4 Cherry Biotech SAS Lung-on-a-chip R&D, and Plans
    4.10 Else Else Kooi Laboratory
        4.10.1 Else Else Kooi Laboratory Company Summary
        4.10.2 Else Else Kooi Laboratory Business Overview
        4.10.3 Else Else Kooi Laboratory Lung-on-a-chip Product Offerings & Technology
        4.10.4 Else Else Kooi Laboratory Lung-on-a-chip R&D, and Plans
    4.11 Micronit Microtechnologies B.V.
        4.11.1 Micronit Microtechnologies B.V. Company Summary
        4.11.2 Micronit Microtechnologies B.V. Business Overview
        4.11.3 Micronit Microtechnologies B.V. Lung-on-a-chip Product Offerings & Technology
        4.11.4 Micronit Microtechnologies B.V. Lung-on-a-chip R&D, and Plans
5 Sights by Region
    5.1 By Region - Global Lung-on-a-chip Market Size, 2025 & 2030
    5.2 By Region - Global Lung-on-a-chip Revenue, (2025-2030)
    5.3 United States
        5.3.1 Key Players of Lung-on-a-chip in United States
        5.3.2 United States Lung-on-a-chip Development Current Situation and Forecast
    5.4 Europe
        5.4.1 Key Players of Lung-on-a-chip in Europe
        5.4.2 Europe Lung-on-a-chip Development Current Situation and Forecast
    5.5 China
        5.5.1 Key Players of Lung-on-a-chip in China
        5.5.2 China Lung-on-a-chip Development Current Situation and Forecast
    5.6 Rest of World
6 Sights by Product
    6.1 By Type - Global Lung-on-a-chip Market Size Markets, 2025 & 2030
    6.2 Pulmonary Inflammation
    6.3 Pulmonary Infection
7 Sights by Application
    7.1 By Application - Global Lung-on-a-chip Market Size, 2025 & 2030
    7.2 Pharmaceutical & Biotechnology Companies
    7.3 Academic & Research Institutes
    7.4 Other End Users
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

NEED Help?

If you need any help or guidance, please feel free to call us.

USA : +1 (661) 636 6162

INDIA : +91 9325802062

or

Write us on : sales@kandjmarketresearch.com